. 2022 Aug 22;8(3):e36244. doi: 10.2196/36244
©Amber S Herbert, Naeemul Hassan, Rena D Malik, Stacy Loeb, Akya Myrie. Originally published in JMIR Cancer (https://cancer.jmir.org), 22.08.2022.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on https://cancer.jmir.org/, as well as this copyright and license information must be included.
Figure 2.
Highest repins for each urological malignancy.